Inside Pharma Leadership

What does it take to successfully scale AI across life sciences—and why are so many AI initiatives falling short? In Part 2 of this conversation, I am joined once again by Parth Khanna, CEO and Co-Founder of ACTO, to explore how AI agents are transforming Learning & Development, commercial teams, and the future of work. Together, they discuss why trust, governance, and human judgment are the m...

AI is reshaping the future of work, but success depends on more than technology. In this episode of Inside Pharma Leadership , I sit down with Parth Khanna, CEO and Co-Founder of ACTO, to explore how AI, agents, and augmented intelligence are transforming learning & development, frontline leadership, and commercial excellence in life sciences. They discuss the evolving role of L&D, why fro...

In Episode 10 of Inside Pharma Leadership , I sit down with David White to explore the journey from scientific discovery to real-world patient impact. From drug development and commercialization to venture capital and biotech innovation, this episode dives into the business and science behind bringing life-changing therapies to market. Meet the Guest David White is a biopharma executive with more...

In this episode, I’m joined by Marshall Spring to discuss the realities behind veteran suicide, the impact of isolation after service, and why rebuilding purpose and community is critical to recovery. Marshall shares how the Combat Recovery Foundation is helping veterans reconnect through service, resilience training, mentorship, and community-driven missions. Meet the Guest Marshall Spring is a c...

In this episode, I’m joined by Christopher Hayden to explore how AI is reshaping quality and compliance in life sciences. From smarter SOPs to human-first tech adoption, they unpack what’s changing—and what still matters most. Meet the Guest Christopher Hayden is a Partner Manager at Scilife, where he works at the intersection of technology, quality, and compliance. With a background spanning scie...

In this episode of Inside Pharma Leadership , I sit down with Maria De Buen , founder of BluePixel , a premier international UX/UI design and software development firm. Maria shares her journey from starting a business straight out of college to leading a 60-person remote team that works with global giants like Office Depot and Philip Morris. The conversation dives deep into the evolution of digit...

Karthik Sriram joins me to share how biotech finance leaders balance science, strategy, and capital to drive innovation. From his journey into the industry to raising over $800M, we unpack what it really takes to fund and scale life sciences companies—and why emotional intelligence is just as critical as financial expertise. Meet the Guest Karthik Sriram is a biotech finance executive currently le...

Kevin Stealey joins me to break down what separates companies that consistently win from those that struggle—and why clarity and alignment are at the core of execution. We also dive into the importance of simplifying complexity in today’s data-heavy, fast-moving organizations. Meet the Guest Kevin Stealey is a seasoned executive with a track record of accelerating profitable growth across consumer...

Unlocking the Secrets of Aging: The Telomere Breakthrough Why hasn't the "cure" for aging been found? According to molecular geneticist Bill Andrews , it’s not a lack of science—it’s a broken system. In this episode, the man who helped discover the "cellular ride tickets" (telomeres) that dictate our lifespan explains why the current biotech model favors profits over cures. We dive into the Hayfli...

Why hasn't the "cure" for aging been found? According to molecular geneticist Bill Andrews , it’s not a lack of science—it’s a broken system. In this episode, the man who helped discover the "cellular ride tickets" (telomeres) that dictate our lifespan explains why the current biotech model favors profits over cures. We dive into the Hayflick Limit , the discovery of Telomerase , and the $130 mill...

In Episode 3 of Inside Pharma Leadership , I sit down with Dr. Angela Tran , CEO & Founder of MedFit Medical Weight Loss , to talk about physician burnout, redefining how medicine is practiced, and what it really takes to achieve long-term, sustainable health. Dr. Tran shares her journey from burnout in traditional healthcare to building a practice centered on “medical fitness”—helping patient...

In Episode 2 of Inside Pharma Leadership, I sit down with Lorrinda Gray-Davis to talk about the intersection of patient experience, healthcare policy, and innovation. Lorrinda shares how her personal journey through end-stage liver disease reshaped her career and led her into transplant advocacy, policy leadership, and building practical tools that help patients navigate access to medications and...

The opioid crisis is the worst healthcare disaster in American history, yet for millions suffering from chronic pain, the only options are addiction or agony. What does it take to build a "Holy Grail" solution when there is no playbook? Steven Fox, a "rare kind of builder," joins us to discuss the high-stakes world of life science innovation, the art of surrounding yourself with "survivors," and w...